| abstract |
Disclosed is a pharmaceutical composition comprising (a) a thienopyridine derivative of formula I wherein R is hydrogen or one to four carbon alkoxycarbonyl or a pharmaceutically acceptable salt thereof, and (b) an HMG-CoA reductase inhibitor. |